“Johnson & Johnson to Air First TV Ad for Drug That Discloses Its Price,” The Wall Street Journal, March 29, 2019. Ads to disclose monthly cost, both before and after insurance. Posting a list price!
Isn’t refreshing to have a marketer tell you up front what the cost will be? Isn’t that information you’d like to have in your decision-making process? Does this demonstrate that the seller is thinking of you differently than other sellers are?
If you’re a competing manufacturer, what does your response or non-response say? Has J&J raised the bar of what information the consumer expects?
This is just Information and Use; I couldn’t really concoct a Governance or Compliance aspect, other than some thoughts about whether the recent $775 million settlement in litigation over the drug at issue factored in.
infogovnuggets 